Transaction Expected to Close on October 1, 2026

NOVI, Mich., Sept. 10, 2026 (GLOBE NEWSWIRE) — Gentherm (NASDAQ:THRM), (the “Company” or “Gentherm”), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced that, at the Company’s Special Meeting of Shareholders (the “Special Meeting”) held today, Gentherm shareholders voted to approve the proposals required to complete the proposed combination of Modine’s Performance Technologies business with Gentherm, including the issuance of shares of Gentherm common stock to shareholders of Modine (NYSE: MOD) and an amendment to Gentherm’s articles of incorporation to increase the number of authorized shares of Gentherm common stock.

The preliminary results of Gentherm’s Special Meeting indicate that approximately 99% of the total votes cast by holders of Gentherm common stock at the Special Meeting were voted in favor of the share issuance proposal, and approximately 94% of the outstanding shares of Gentherm common stock entitled to vote thereon were voted in favor of the charter amendment proposal. The final vote results, as certified by the inspector of elections, will be reported in a Form 8-K filed with the U.S. Securities and Exchange Commission (the “SEC”).

“We appreciate the continued support of our shareholders for this important transaction,” said Bill Presley, the Company’s President and CEO. “This transaction accelerates our transformation to building a higher growth and higher margin, thermal and precision flow management business. The combined business is well positioned to drive meaningful profitable growth across multiple attractive end markets.”

Gentherm and Modine have also received all of the required regulatory approvals, including Modine’s receipt of a Private Letter Ruling from the Internal Revenue Service regarding matters relating to the U.S. federal income tax consequences of the transaction. The final exchange ratio will be announced in connection with the closing and remains subject to potential adjustment as provided in the merger agreement. The exchange ratio adjustment mechanism is designed to preserve the intended tax-free nature of certain aspects of the transaction for U.S. federal income tax purposes to Modine and Modine shareholders on one hand, and the economic allocation between the Modine shareholders and the Gentherm shareholders on the other. The transaction is currently expected to close on October 1, 2026, subject to the satisfaction or waiver of the remaining customary closing conditions.

Investor Contact 
Gregory Blanchette
investors@gentherm.com  
248.308.1702 

Media Contact 
Haley Baur 
media@gentherm.com  
248.289.9711

About Gentherm
Gentherm (NASDAQ: THRM) is a global market leader of innovative thermal management and pneumatic comfort technologies. Automotive products include Climate Control Seats (CCS®), Climate Control Interiors (CCI™), Lumbar and Massage Comfort Solutions, and Valve Systems. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities across 13 countries. In 2025, the company recorded annual sales of approximately $1.5 billion and secured $2.2 billion in automotive new business awards. For more information, go to www.gentherm.com. 

Forward-Looking Statements 
This release includes “forward-looking statements” as that term is defined in Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding the proposed combination of Modine’s Performance Technologies business with Gentherm (the “Proposed Transaction”). These forward-looking statements may be identified by the words “believe,” “feel,” “project,” “expect,” “anticipate,” “appear,” “estimate,” “forecast,” “outlook,” “target,” “endeavor,” “seek,” “predict,” “intend,” “suggest,” “strategy,” “plan,” “may,” “could,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” or the negative thereof or variations thereon or similar terminology generally intended to identify forward-looking statements. . These forward-looking statements represent Gentherm’s goals, beliefs, plans and expectations about its prospects for the future and other future events. The forward-looking statements included in this release are made as of the date hereof or as of the date specified herein and are based on management’s reasonable expectations and beliefs. In making these statements, we rely on assumptions and analysis based on our experience and perception of historical trends, current conditions and expected future developments, third party information and projections from sources that management believes to be reputable, as well as other factors we consider appropriate under the circumstances. Such statements are subject to a number of important assumptions, significant risks and uncertainties (some of which are beyond our control) and other factors that may cause actual results or performance to differ materially from that described in or indicated by the forward-looking statements, including but not limited to:

  • macroeconomic, geopolitical and similar global factors in the cyclical Automotive industry;
  • the impact of, and our ability to mitigate the effects of, global economic and trade policies, including increases in duties, tariffs and taxation on the import or export of our products related to U.S. trade disputes;
  • increasing U.S. and global competition, including with non-traditional entrants;
  • our ability to effectively manage new product launches and research and development, and the market acceptance of such products and technologies;
  • the evolution and challenges of the automotive industry towards electric vehicles, autonomous vehicles and mobility on demand services, and related consumer behaviors and preferences;
  • our ability to convert automotive new business awards into product revenues;
  • the constraints in the supply chain environment, and inflationary and other cost pressures;
  • the production levels of our major customers and OEMs in our relevant markets and sudden fluctuations in such production levels;
  • our business in China, which is subject to unique operational, competitive, geopolitical, regulatory and economic risks;
  • the impact of our global operations, including our cost structure and global manufacturing footprint, operations within Ukraine, and foreign currency and exchange risk;
  • our product quality and safety and impact of product safety recalls and alleged defects in products;
  • our ability to attract and retain highly skilled employees and wage inflation;
  • a tightening labor market, labor shortages or work stoppages impacting us, our customers or our suppliers, such as recent labor strikes among certain OEMs and suppliers;
  • our achievement of product cost reductions to offset customer-imposed price reductions or other pricing pressures;
  • our ability to execute efforts to optimize our global supply chain and manufacturing footprint, including opening new facilities and transferring production;
  • our ability to source, consummate, integrate and achieve planned benefits of strategic acquisitions, investments and, as applicable, exits;
  • any security breaches and other disruptions to our information technology networks and systems, as well as privacy, data security and data protection risks, including risks associated with use of artificial intelligence capabilities in our business operations;
  • any loss or insolvency of our key customers and OEMs, or key suppliers;
  • our ability to project future sales volume based on third-party information, based on which we manage our business;
  • the protection of our intellectual property in certain jurisdictions;
  • our compliance with global anti-corruption laws and regulations;
  • legal and regulatory proceedings and claims involving us or one of our major customers;
  • the extensive regulation of our patient temperature management business;
  • risks associated with our manufacturing processes;
  • the effects of climate change and regulatory and stakeholder-imposed requirements to address climate change and other sustainability issues;
  • our borrowing availability under our revolving credit facility, as well as the ability to access the capital markets, to support our planned growth; and
  • our indebtedness and compliance with our debt covenants.

Furthermore, important factors related to the Proposed Transaction could cause actual results to differ materially from those currently anticipated, including:

  • that one or more closing conditions to the Proposed Transaction may not be satisfied or waived, on a timely basis or otherwise;
  • the risk that the Proposed Transaction may not be completed on the terms or in the time frame expected by Gentherm, Modine and  Platinum SpinCo Inc. (“SpinCo”), or at all;
  • unexpected costs, charges or expenses resulting from the Proposed Transaction;
  • uncertainty of the expected financial performance of the combined company following completion of the Proposed Transaction;
  • failure to realize the anticipated benefits of the Proposed Transaction, including as a result of delay in completing the Proposed Transaction or integrating the businesses of Gentherm and SpinCo, on the expected timeframe or at all;
  • the ability of the combined company to implement its business strategy;
  • difficulties and delays in the combined company achieving revenue and cost synergies;
  • inability of the combined company to retain and hire key personnel;
  • the occurrence of any event that could give rise to termination of the Proposed Transaction;
  • the risk that shareholder litigation in connection with the Proposed Transaction or other litigation, settlements or investigations may affect the timing or occurrence of the Proposed Transaction or result in significant costs of defense, indemnification and liability;
  • evolving legal, regulatory and tax regimes;
  • changes in general economic and/or industry specific conditions or any volatility resulting from the imposition of and changing policies, including those policies with respect to tariffs;
  • actions by third parties, including government agencies;
  • the risk of greater than expected difficulty in separating the business of SpinCo from the other businesses of Modine; and
  • risks related to the disruption of management time from ongoing business operations due to the pendency of the Proposed Transaction, or other effects of the pendency of the Proposed Transaction on the relationship of any of the parties to the Proposed Transaction with their employees, customers, suppliers, or other counterparties.

The foregoing risks should be read in conjunction with the Company’s reports filed with or furnished to the SEC, including “Risk Factors,” in its most recent Annual Report on Form 10-K and subsequent SEC filings including the Company’s registration statement on Form S-4, which was declared effective by the SEC on August 12, 2026, for a discussion of these and other risks and uncertainties. In addition, with reasonable frequency, we have entered into business combinations, acquisitions, divestitures, strategic investments and other significant transactions. Such forward-looking statements do not include the potential impact of any such transactions that may be completed after the date hereof (except the Proposed Transaction to the extent specified), each of which may present material risks to the Company’s future business and financial results. Moreover, we operate in a very competitive and rapidly changing environment and new risks emerge from time to time.

Except as required by law, the Company expressly disclaims any obligation or undertaking to update any forward-looking statements to reflect any change in its strategies or expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. 

Hamilton Global Opportunities plc (ALHGO.PA) published its
2026 half-year financial results: Net assets up 20.5% to €24.95 million

Highlights for the first half of 2026:

  • Net assets of €24 949 881 as of June 30, 2026, up 20.5% compared with 30 June 2025
  • Cash and short-term financial investments of €4.87 million, compared with €0.69 million as of 30 June 2025
  • Dividend of €3.44 per share paid to shareholders in May 2026
  • Pre-tax loss for the period of €1 279 512 compared with €2.58 million in the first half of 2025
  • Follow on investments to support their development in:
    • AntariaPharma, a tech-enabled, alternative lending platform specialised in pharmacies.
    • Exos Financial a technology-driven institutional investment banking and alternative asset platform.

London, UK, September 10, 2026, 18:00 BST – Hamilton Global Opportunities plc, an investment company listed on Euronext Growth Paris, provides 2026 half-year financial statements and operation report. The 2026 half-year financial report is available on the company’s website, in the Latest Updates section (hamiltongo.eu).

PERFORMANCE

Assets as of 30 June 2026 (in €)

   
  June 30, 2026 June 30, 2025
Tangible assets 9 239 58 472
Investments 25 132 705 22 659 280
Fixed Assets 25 141 944 22 716 480
Trade and other receivables 160 312 113 769
Cash at bank and in hand 114 475 298 939
Financial Assets 4 754 367 386 881
Total Assets 30 171 098 23 574 541
Liabilities (excluding deferred tax) (5 221 217) (2 871 542)
Net assets 24 949 881 20 702 999

Significant growth in net assets

Net Assets stood at €24.94m vs €20.70m as of 30 June 2025. The change in Net Assets during the first half of 2026 compared to the same period in 2025 resulted mainly from the profit realised from the sale of the majority of the position held in MIAX and the continued strong performance of the investments in both AntariaPharma and Exos Financial as well as an improvement in the EUR/USD exchange rate in favour of the USD.

This increase was achieved despite the payment to shareholders in May 2026 of a total dividend of €2.17 million, equivalent to €3.44 per share.

As of 30 June 2026 the accounts show a pre-tax loss for the period of €1 279 512 compared to a loss before tax of €2 579 173 at the end of June 2025. The operating loss for June 2026 is almost solely due to the continued underperformance in Hamilton’s investment in Gauzy Ltd.

A strengthened cash position

Hamilton’s net cash position including short term liquid investments was €4 868 842 as of June 2026 compared to €685 820 as of 30 June 2025. This increase is mainly due to the profits realized from the sale of the majority of the position held in MIAX.

A solid Balance Sheet

Hamilton’s balance sheet remains strong with liabilities unchanged compared to December 2025 at €3.5 million, including USD denominated debt with a Euro equivalent value of €3.16 million. After deduction of the liabilities and the dividend paid in May 2026 the Hamilton’s net asset value remained stable at €24.94 million at the end of June 2026.

Payment of a €3.44 dividend per share

In May 2026, Hamilton confirmed its commitment to return capital to shareholders where possible through the distribution of a dividend of €3.44 per share representing an 8.00% yield. The distribution of the dividend was made possible following the exit of the majority of Hamilton’s holdings in MIAX in December 2025.

Foreign Exchange

During the period the USD dollar strengthened against the Euro providing a foreign exchange gain on investments compared to a significant loss in the same period in 2025. Although volatile due to the current geo-political situation management maintains the view that the exchange rate will stabilise over the long term and that foreign exchange hedging would be an unnecessary and significant expense in light of the Hamilton’s investment strategy.

Continued support for portfolio companies

The investment portfolio continues to perform well overall with the notable exception of Gauzy Ltd which remains mired in legal proceedings in both France and Israel.

In line with its investment strategy Hamilton continues to support its investee companies and has made additional investments to help fund growth in both AntariaPharma and Exos Financial both of which are continuing to show strong growth prospects.

The portfolio’s overall performance nevertheless continues to be affected by the adverse performance of Hamilton’s listed holding in Gauzy Ltd, against a backdrop of ongoing legal proceedings in France and Israel.

Post Closing Events

Hamilton has a USD 3.1million note issue due to mature in October 2026.

Investors will have the choice to convert into the listed shares of Hamilton or use the proceeds from this note redemption to reinvest in another Hamilton note issue due 15 February 2030.

Hamilton also has the right, with one months’ notice prior to maturity, to extend the maturity of the notes maturing on 15th October 2026 for a further 12 months.

As of 30 June 2026, Hamilton has sufficient cash reserves to meet all of its current liabilities including the upcoming note maturity.

Gustavo Perrotta, Founder and Chief Executive Officer of Hamilton Global Opportunities plc declares:

“Despite the continued underperformance of Gauzy Ltd the remainder of the investment portfolio, notably AntariaPharma and Exos Financial, continues to show strong performance and growth. Following the successful exit of the majority of our holdings in MIAX at the end of 2025 we were particularly happy to be able to pay a dividend of €3.44 per share to our shareholders. The payment of the dividend has had an impact on our net asset value and cash position but remains an important part of our long-standing commitment to return capital to our shareholders where possible. Our cash position remains healthy and we have established a strong platform for continued growth over the coming years. ”

About Hamilton Global Opportunities

Hamilton Global Opportunities plc (“HGO”), founded in 2009 and listed on the Euronext Growth market since April 2021, focuses on providing capital solutions to growth stage companies which have a strong technology bias. The HGO management team has significant relevant experience in structuring direct investments in the areas above mentioned. For more information, please visit: hamiltongo.eu

Contact

Hamilton Global Opportunities
Gustavo Perrotta
Founder & CEO
gp@hamiltongo.eu
Gavin Alexander
Director & CRO
ga@hamiltongo.eu

Hamilton Global Opportunities plc (ALHGO.PA) published its
2026 half-year financial results: Net assets up 20.5% to €24.95 million

Highlights for the first half of 2026:

  • Net assets of €24 949 881 as of June 30, 2026, up 20.5% compared with 30 June 2025
  • Cash and short-term financial investments of €4.87 million, compared with €0.69 million as of 30 June 2025
  • Dividend of €3.44 per share paid to shareholders in May 2026
  • Pre-tax loss for the period of €1 279 512 compared with €2.58 million in the first half of 2025
  • Follow on investments to support their development in:
    • AntariaPharma, a tech-enabled, alternative lending platform specialised in pharmacies.
    • Exos Financial a technology-driven institutional investment banking and alternative asset platform.

London, UK, September 10, 2026, 18:00 BST – Hamilton Global Opportunities plc, an investment company listed on Euronext Growth Paris, provides 2026 half-year financial statements and operation report. The 2026 half-year financial report is available on the company’s website, in the Latest Updates section (hamiltongo.eu).

PERFORMANCE

Assets as of 30 June 2026 (in €)

   
  June 30, 2026 June 30, 2025
Tangible assets 9 239 58 472
Investments 25 132 705 22 659 280
Fixed Assets 25 141 944 22 716 480
Trade and other receivables 160 312 113 769
Cash at bank and in hand 114 475 298 939
Financial Assets 4 754 367 386 881
Total Assets 30 171 098 23 574 541
Liabilities (excluding deferred tax) (5 221 217) (2 871 542)
Net assets 24 949 881 20 702 999

Significant growth in net assets

Net Assets stood at €24.94m vs €20.70m as of 30 June 2025. The change in Net Assets during the first half of 2026 compared to the same period in 2025 resulted mainly from the profit realised from the sale of the majority of the position held in MIAX and the continued strong performance of the investments in both AntariaPharma and Exos Financial as well as an improvement in the EUR/USD exchange rate in favour of the USD.

This increase was achieved despite the payment to shareholders in May 2026 of a total dividend of €2.17 million, equivalent to €3.44 per share.

As of 30 June 2026 the accounts show a pre-tax loss for the period of €1 279 512 compared to a loss before tax of €2 579 173 at the end of June 2025. The operating loss for June 2026 is almost solely due to the continued underperformance in Hamilton’s investment in Gauzy Ltd.

A strengthened cash position

Hamilton’s net cash position including short term liquid investments was €4 868 842 as of June 2026 compared to €685 820 as of 30 June 2025. This increase is mainly due to the profits realized from the sale of the majority of the position held in MIAX.

A solid Balance Sheet

Hamilton’s balance sheet remains strong with liabilities unchanged compared to December 2025 at €3.5 million, including USD denominated debt with a Euro equivalent value of €3.16 million. After deduction of the liabilities and the dividend paid in May 2026 the Hamilton’s net asset value remained stable at €24.94 million at the end of June 2026.

Payment of a €3.44 dividend per share

In May 2026, Hamilton confirmed its commitment to return capital to shareholders where possible through the distribution of a dividend of €3.44 per share representing an 8.00% yield. The distribution of the dividend was made possible following the exit of the majority of Hamilton’s holdings in MIAX in December 2025.

Foreign Exchange

During the period the USD dollar strengthened against the Euro providing a foreign exchange gain on investments compared to a significant loss in the same period in 2025. Although volatile due to the current geo-political situation management maintains the view that the exchange rate will stabilise over the long term and that foreign exchange hedging would be an unnecessary and significant expense in light of the Hamilton’s investment strategy.

Continued support for portfolio companies

The investment portfolio continues to perform well overall with the notable exception of Gauzy Ltd which remains mired in legal proceedings in both France and Israel.

In line with its investment strategy Hamilton continues to support its investee companies and has made additional investments to help fund growth in both AntariaPharma and Exos Financial both of which are continuing to show strong growth prospects.

The portfolio’s overall performance nevertheless continues to be affected by the adverse performance of Hamilton’s listed holding in Gauzy Ltd, against a backdrop of ongoing legal proceedings in France and Israel.

Post Closing Events

Hamilton has a USD 3.1million note issue due to mature in October 2026.

Investors will have the choice to convert into the listed shares of Hamilton or use the proceeds from this note redemption to reinvest in another Hamilton note issue due 15 February 2030.

Hamilton also has the right, with one months’ notice prior to maturity, to extend the maturity of the notes maturing on 15th October 2026 for a further 12 months.

As of 30 June 2026, Hamilton has sufficient cash reserves to meet all of its current liabilities including the upcoming note maturity.

Gustavo Perrotta, Founder and Chief Executive Officer of Hamilton Global Opportunities plc declares:

“Despite the continued underperformance of Gauzy Ltd the remainder of the investment portfolio, notably AntariaPharma and Exos Financial, continues to show strong performance and growth. Following the successful exit of the majority of our holdings in MIAX at the end of 2025 we were particularly happy to be able to pay a dividend of €3.44 per share to our shareholders. The payment of the dividend has had an impact on our net asset value and cash position but remains an important part of our long-standing commitment to return capital to our shareholders where possible. Our cash position remains healthy and we have established a strong platform for continued growth over the coming years. ”

About Hamilton Global Opportunities

Hamilton Global Opportunities plc (“HGO”), founded in 2009 and listed on the Euronext Growth market since April 2021, focuses on providing capital solutions to growth stage companies which have a strong technology bias. The HGO management team has significant relevant experience in structuring direct investments in the areas above mentioned. For more information, please visit: hamiltongo.eu

Contact

Hamilton Global Opportunities
Gustavo Perrotta
Founder & CEO
gp@hamiltongo.eu
Gavin Alexander
Director & CRO
ga@hamiltongo.eu

SalMar ASA (rated BBB by Nordic Credit Rating) has today, 10 September 2026, issued two new commercial papers, with a nominal amount of NOK 1,000 million and NOK 250 million, both papers have an issue date of 15 September 2026 and maturity date of 15 September 2027.

Commercial paper FRN:
Nominal amount: NOK 1,000 million, with a limit of NOK 1,500 million
Coupon: 3-month NIBOR + 47 basis points

Commercial paper Fixed Rate:
Nominal amount: NOK 250 million, with a limit of NOK 500 million
Coupon: 5.37% p.a.

Manager: DNB Carnegie

This information is subject to the disclosure requirements stipulated in section 5-12 of the Norwegian Securities Trading Act.

Monthly information on number of shares and voting rights
of Quadient S.A.

In accordance with article 223.11 of Autorité des marchés financiers’
(French Securities and Investment board) General Regulations

Ordinary shares – ISIN: FR0000120560

  As at August 31, 2026
Total number of shares 34,468,912
Theoretical total number of voting rights 34,468,912
Net total number of voting rights 34,080,466

For more information, please contact:

Laura Paxton, Quadient
+33 (0)6 07 30 33 86
l.paxton@quadient.com
financial-communication@quadient.com
 

Or visit our website: https://invest.quadient.com/

Attachment

Monthly information on number of shares and voting rights
of Quadient S.A.

In accordance with article 223.11 of Autorité des marchés financiers’
(French Securities and Investment board) General Regulations

Ordinary shares – ISIN: FR0000120560

  As at August 31, 2026
Total number of shares 34,468,912
Theoretical total number of voting rights 34,468,912
Net total number of voting rights 34,080,466

For more information, please contact:

Laura Paxton, Quadient
+33 (0)6 07 30 33 86
l.paxton@quadient.com
financial-communication@quadient.com
 

Or visit our website: https://invest.quadient.com/

Attachment

Octopus AIM VCT 2 plc

Net Asset Value

Octopus AIM VCT 2 plc announces that as at 31 August 2026 the unaudited net asset value of the Ordinary shares was approximately 32.0 pence per share.

For further information, please contact:

Andrew Humphries
Octopus Company Secretarial Services Limited
Tel: +44 (0)80 0316 2067

LEI: 213800BW27BKJCI35L17

Octopus AIM VCT 2 plc

Net Asset Value

Octopus AIM VCT 2 plc announces that as at 31 August 2026 the unaudited net asset value of the Ordinary shares was approximately 32.0 pence per share.

For further information, please contact:

Andrew Humphries
Octopus Company Secretarial Services Limited
Tel: +44 (0)80 0316 2067

LEI: 213800BW27BKJCI35L17

CALGARY, Canada–(BUSINESS WIRE)–Blackline Safety, a global leader in connected safety technology, will feature its new G8 connected safety wearable at the 2026 National Safety Council (NSC) Safety Congress and Expo in Indianapolis, Indiana, following strong early customer adoption. Since G8 began shipping in March 2026, both new and long-standing Blackline customers have moved to the next generation of connected safety technology. G8 combines connected gas detection, lone worker protection, t

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.